Welcome to BIOAXXESS®!
BIOAXXESS® is a private independent technology & business development agency formed as a network of experts with academic and commercial background since 2003. BIOAXXESS® clients include Dx, Rx, clinical research centres and SME as innovative technology providers.
SMi
Biomarker Summit, London, UK 4-5th February 2008
BIOAXXESS® is delighted to present PEVIVA
AB, based in Bromma Sweden as the developer and manufacturer of
high quality immunoassays to monitor epithelial cell death in
vitro as well as in vivo.
PEVIVA's first-in-class
CE-certified cell death biomarker assays M65 ELISA® and
M30-Apoptosense® ELISA have been independently validated by
pharmaceutical companies and clinical research centres for
diagnostic use in oncology and hepatology.
"Production,
marketing and sales of biomarker assays to be used for drug
development and clinical studies" from PEVIVA are
quality-certified according to ISO 9001:2000 and ISO
13485:2003.
PEVIVA unique cell death biomarker
immunoassays are successfully used by >10 of the top 20 largest
pharmaceutical and biotech companies worldwide allowing
evidence-based decisions in discovery, preclinical and clinical
drug development.
At the moment clinical research centres
evaluate new applications for both the M30-Apoptosense® ELISA
and M65 ELISA® in disease monitoring and treatment management.
To learn about PEVIVA products in more detail and how to
order please visit:
In addition to providing expert advice on all aspects
of the PEVIVA Cell Death Biomarker Assay Product Line,
BIOAXXESS® also serves as your point of contact for their
biomarker technology in the UK.
New! September
2007
BIOAXXESS® your expert technology consultancy for biomarker assay
development, optimization and validation is excited to announce
our partnership with CANDOR
Bioscience GmbH,
based in Bavarian Weissensberg, Germany: the technology solution
provider for optimizing your immunoassays.
In addition
to providing bespoke advice on all aspects of the CANDOR
Bioscience Buffer Product Line, BIOAXXESS® also serves as your local UK distributor
the optimal (buffer) solution for every immunoassay
application!
CANDOR specially developed range of buffer
products - with the unique LowCross-Buffer® flagship - are high quality tools manufactured under DIN
EN ISO 9001:2000 to let you achieve superior reliability and
performance of immunoassays such as ELISA, Western blot, IHC,
protein chips. CANDOR buffer systems are successfully used in
research, pharmaceutical development and routine diagnostic
tests worldwide.
To learn about CANDOR products and
services in more detail please visit:
For further technology advice, to order CANDOR buffer solutions and to find out about what BIOAXXESS® and CANDOR services could do for your biomarker assay development & validation, please contact: info@bioaxxess.com
To further strengthen our services in M&S and training & development, BIOAXXESS® has now moved offices to
Malvern Hills Science Park, Geraldine Road,WR14 3SZ Malvern,
Worcestershire, United Kingdom.
While the new BIOAXXESS® website is under
construction, please contact
Dr Frank Neumann, Principal, Adviser |
BIOAXXESS® main areas of business
activities are
-
Technology Consulting and Business Development
-
Training & Development through tutorials and executive briefings
-
Strategic targeted Marketing & Sales
BIOAXXESS® offers:
-
scouting of Rx & Dx technology trends in oncology, hepatology and infection & inflammation
-
product and technology assessment, expert reports & privileged procurement
-
sourcing and promoting highly innovative technology solutions or products of outstanding quality and performance
-
creating collaborative interactions between technology solution providers and pharmaceutical and clinical clients
-
pro-active M&S activities in accordance with client corporate ID and efficiency in low risk resource management
-
tailor made business contract solutions, targeted campaigns and technology training initiatives & workshops

